Literatur
- 1
Pitt B .
Remme W .
Zannad T .
et al .
for the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival
Study Investigators. Eplerenone, a Selective Aldosterone Blocker, in Patients with
Left Ventricular Dysfunction after Myocardial Infarction.
N Engl J Med.
2003;
348
1309-1321
- 2
Pitt B .
et al .
Eplerenone Reduces Mortality 30 Days After Randomization Following Acute Myocardial
Infarction in Patients With Left Ventricular Systolic Dysfunction and Heart Failure.
J Am Coll Cardiol.
2005;
46
425-431
1 Inspra®, Pfizer Pharma GmbH
